LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

Uncharacterized protein

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
Uncharacterized protein
Gene product:
acyl transferase-like protein - putative
Species:
Leishmania infantum
UniProt:
A4IBN7_LEIIN
TriTrypDb:
LINF_350040100
Length:
532

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 10
NetGPI no yes: 0, no: 10
Cellular components
Term Name Level Count
GO:0005835 fatty acid synthase complex 3 2
GO:0032991 protein-containing complex 1 2
GO:0140535 intracellular protein-containing complex 2 2
GO:1902494 catalytic complex 2 2

Expansion

Sequence features

A4IBN7
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: A4IBN7

Function

Biological processes
Term Name Level Count
GO:0006082 organic acid metabolic process 3 3
GO:0006629 lipid metabolic process 3 3
GO:0006631 fatty acid metabolic process 4 3
GO:0006633 fatty acid biosynthetic process 5 3
GO:0008152 metabolic process 1 3
GO:0008610 lipid biosynthetic process 4 3
GO:0009058 biosynthetic process 2 3
GO:0009987 cellular process 1 3
GO:0016053 organic acid biosynthetic process 4 3
GO:0019752 carboxylic acid metabolic process 5 3
GO:0032787 monocarboxylic acid metabolic process 6 3
GO:0043436 oxoacid metabolic process 4 3
GO:0044237 cellular metabolic process 2 3
GO:0044238 primary metabolic process 2 3
GO:0044249 cellular biosynthetic process 3 3
GO:0044255 cellular lipid metabolic process 3 3
GO:0044281 small molecule metabolic process 2 3
GO:0044283 small molecule biosynthetic process 3 3
GO:0046394 carboxylic acid biosynthetic process 5 3
GO:0071704 organic substance metabolic process 2 3
GO:0072330 monocarboxylic acid biosynthetic process 6 3
GO:1901576 organic substance biosynthetic process 3 3
Molecular functions
Term Name Level Count
GO:0003824 catalytic activity 1 11
GO:0016740 transferase activity 2 11
GO:0004312 fatty acid synthase activity 5 3
GO:0004314 [acyl-carrier-protein] S-malonyltransferase activity 6 1
GO:0016417 S-acyltransferase activity 5 1
GO:0016419 S-malonyltransferase activity 6 1
GO:0016420 malonyltransferase activity 5 1
GO:0016746 acyltransferase activity 3 3
GO:0016747 acyltransferase activity, transferring groups other than amino-acyl groups 4 3

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 275 279 PF00656 0.531
CLV_C14_Caspase3-7 91 95 PF00656 0.441
CLV_NRD_NRD_1 177 179 PF00675 0.453
CLV_NRD_NRD_1 307 309 PF00675 0.590
CLV_NRD_NRD_1 358 360 PF00675 0.445
CLV_NRD_NRD_1 394 396 PF00675 0.566
CLV_NRD_NRD_1 504 506 PF00675 0.565
CLV_PCSK_KEX2_1 161 163 PF00082 0.319
CLV_PCSK_KEX2_1 307 309 PF00082 0.555
CLV_PCSK_KEX2_1 358 360 PF00082 0.445
CLV_PCSK_KEX2_1 394 396 PF00082 0.606
CLV_PCSK_KEX2_1 425 427 PF00082 0.530
CLV_PCSK_KEX2_1 496 498 PF00082 0.509
CLV_PCSK_KEX2_1 504 506 PF00082 0.414
CLV_PCSK_KEX2_1 71 73 PF00082 0.421
CLV_PCSK_PC1ET2_1 161 163 PF00082 0.368
CLV_PCSK_PC1ET2_1 425 427 PF00082 0.491
CLV_PCSK_PC1ET2_1 496 498 PF00082 0.506
CLV_PCSK_PC1ET2_1 71 73 PF00082 0.421
CLV_PCSK_PC7_1 303 309 PF00082 0.552
CLV_PCSK_SKI1_1 162 166 PF00082 0.319
CLV_PCSK_SKI1_1 199 203 PF00082 0.377
CLV_PCSK_SKI1_1 2 6 PF00082 0.397
CLV_PCSK_SKI1_1 308 312 PF00082 0.577
CLV_PCSK_SKI1_1 369 373 PF00082 0.430
CLV_PCSK_SKI1_1 379 383 PF00082 0.396
CLV_PCSK_SKI1_1 457 461 PF00082 0.504
DEG_Nend_UBRbox_1 1 4 PF02207 0.487
DEG_SPOP_SBC_1 213 217 PF00917 0.512
DOC_CYCLIN_RxL_1 159 167 PF00134 0.447
DOC_CYCLIN_RxL_1 376 385 PF00134 0.516
DOC_CYCLIN_yCln2_LP_2 22 28 PF00134 0.399
DOC_MAPK_gen_1 338 346 PF00069 0.414
DOC_MAPK_gen_1 394 401 PF00069 0.542
DOC_MAPK_gen_1 435 444 PF00069 0.603
DOC_MAPK_gen_1 514 522 PF00069 0.523
DOC_MAPK_MEF2A_6 339 348 PF00069 0.413
DOC_MAPK_MEF2A_6 514 522 PF00069 0.523
DOC_MAPK_RevD_3 147 162 PF00069 0.335
DOC_PP1_RVXF_1 197 203 PF00149 0.368
DOC_USP7_MATH_1 134 138 PF00917 0.335
DOC_USP7_MATH_1 213 217 PF00917 0.548
DOC_USP7_MATH_1 268 272 PF00917 0.442
DOC_USP7_MATH_1 293 297 PF00917 0.658
DOC_USP7_MATH_1 351 355 PF00917 0.372
DOC_USP7_MATH_1 58 62 PF00917 0.324
DOC_WW_Pin1_4 148 153 PF00397 0.355
DOC_WW_Pin1_4 181 186 PF00397 0.493
DOC_WW_Pin1_4 315 320 PF00397 0.528
DOC_WW_Pin1_4 491 496 PF00397 0.490
LIG_14-3-3_CanoR_1 303 307 PF00244 0.562
LIG_14-3-3_CanoR_1 33 39 PF00244 0.441
LIG_14-3-3_CanoR_1 497 503 PF00244 0.475
LIG_14-3-3_CanoR_1 504 509 PF00244 0.448
LIG_14-3-3_CanoR_1 516 521 PF00244 0.523
LIG_14-3-3_CanoR_1 72 80 PF00244 0.411
LIG_14-3-3_CanoR_1 85 93 PF00244 0.331
LIG_Actin_WH2_2 343 360 PF00022 0.434
LIG_BRCT_BRCA1_1 499 503 PF00533 0.517
LIG_BRCT_BRCA1_1 60 64 PF00533 0.441
LIG_FHA_1 316 322 PF00498 0.541
LIG_FHA_1 403 409 PF00498 0.518
LIG_FHA_1 439 445 PF00498 0.475
LIG_FHA_1 458 464 PF00498 0.194
LIG_FHA_1 73 79 PF00498 0.441
LIG_FHA_1 85 91 PF00498 0.441
LIG_FHA_2 326 332 PF00498 0.567
LIG_FHA_2 474 480 PF00498 0.460
LIG_FHA_2 89 95 PF00498 0.429
LIG_IRF3_LxIS_1 378 385 PF10401 0.377
LIG_LIR_Apic_2 341 345 PF02991 0.403
LIG_LIR_Gen_1 140 149 PF02991 0.335
LIG_LIR_Gen_1 215 226 PF02991 0.442
LIG_LIR_LC3C_4 439 444 PF02991 0.494
LIG_LIR_Nem_3 140 144 PF02991 0.377
LIG_LIR_Nem_3 198 204 PF02991 0.417
LIG_LIR_Nem_3 215 221 PF02991 0.315
LIG_LIR_Nem_3 304 309 PF02991 0.558
LIG_LIR_Nem_3 341 346 PF02991 0.404
LIG_LIR_Nem_3 362 367 PF02991 0.389
LIG_LRP6_Inhibitor_1 221 227 PF00058 0.450
LIG_NRBOX 377 383 PF00104 0.419
LIG_PALB2_WD40_1 338 346 PF16756 0.457
LIG_PCNA_TLS_4 358 365 PF02747 0.432
LIG_SH2_STAT3 101 104 PF00017 0.426
LIG_SH2_STAT3 126 129 PF00017 0.402
LIG_SH2_STAT5 101 104 PF00017 0.384
LIG_SH2_STAT5 231 234 PF00017 0.362
LIG_SH3_3 146 152 PF00018 0.355
LIG_SH3_3 405 411 PF00018 0.514
LIG_SUMO_SIM_anti_2 215 223 PF11976 0.419
LIG_SUMO_SIM_par_1 380 385 PF11976 0.384
LIG_SUMO_SIM_par_1 439 446 PF11976 0.567
LIG_TRAF2_1 328 331 PF00917 0.624
LIG_TRAF2_1 477 480 PF00917 0.524
LIG_TYR_ITIM 113 118 PF00017 0.451
LIG_UBA3_1 381 386 PF00899 0.512
LIG_WRC_WIRS_1 444 449 PF05994 0.555
MOD_CDC14_SPxK_1 184 187 PF00782 0.577
MOD_CDC14_SPxK_1 494 497 PF00782 0.520
MOD_CDK_SPK_2 491 496 PF00069 0.484
MOD_CDK_SPxK_1 181 187 PF00069 0.517
MOD_CDK_SPxK_1 491 497 PF00069 0.500
MOD_CK1_1 151 157 PF00069 0.424
MOD_CK1_1 191 197 PF00069 0.499
MOD_CK1_1 263 269 PF00069 0.526
MOD_CK1_1 302 308 PF00069 0.673
MOD_CK1_1 507 513 PF00069 0.496
MOD_CK1_1 524 530 PF00069 0.534
MOD_CK2_1 134 140 PF00069 0.335
MOD_CK2_1 214 220 PF00069 0.403
MOD_CK2_1 317 323 PF00069 0.562
MOD_CK2_1 325 331 PF00069 0.589
MOD_CK2_1 416 422 PF00069 0.552
MOD_CK2_1 473 479 PF00069 0.524
MOD_GlcNHglycan 256 259 PF01048 0.629
MOD_GlcNHglycan 295 298 PF01048 0.603
MOD_GlcNHglycan 334 337 PF01048 0.426
MOD_GlcNHglycan 418 421 PF01048 0.530
MOD_GlcNHglycan 448 451 PF01048 0.483
MOD_GlcNHglycan 7 10 PF01048 0.317
MOD_GSK3_1 208 215 PF00069 0.435
MOD_GSK3_1 263 270 PF00069 0.461
MOD_GSK3_1 512 519 PF00069 0.515
MOD_GSK3_1 520 527 PF00069 0.530
MOD_GSK3_1 80 87 PF00069 0.470
MOD_N-GLC_1 156 161 PF02516 0.266
MOD_N-GLC_1 188 193 PF02516 0.533
MOD_N-GLC_1 402 407 PF02516 0.373
MOD_N-GLC_1 497 502 PF02516 0.527
MOD_NEK2_1 156 161 PF00069 0.363
MOD_NEK2_1 17 22 PF00069 0.338
MOD_NEK2_1 212 217 PF00069 0.423
MOD_NEK2_1 292 297 PF00069 0.548
MOD_NEK2_1 352 357 PF00069 0.380
MOD_NEK2_1 399 404 PF00069 0.404
MOD_NEK2_1 416 421 PF00069 0.319
MOD_NEK2_1 438 443 PF00069 0.543
MOD_NEK2_1 5 10 PF00069 0.323
MOD_NEK2_1 520 525 PF00069 0.471
MOD_NEK2_1 80 85 PF00069 0.433
MOD_NEK2_1 97 102 PF00069 0.262
MOD_NEK2_2 268 273 PF00069 0.522
MOD_PIKK_1 100 106 PF00454 0.367
MOD_PK_1 514 520 PF00069 0.472
MOD_PKA_1 338 344 PF00069 0.416
MOD_PKA_1 496 502 PF00069 0.500
MOD_PKA_1 504 510 PF00069 0.407
MOD_PKA_2 302 308 PF00069 0.561
MOD_PKA_2 32 38 PF00069 0.383
MOD_PKA_2 496 502 PF00069 0.486
MOD_PKA_2 504 510 PF00069 0.434
MOD_PKA_2 84 90 PF00069 0.266
MOD_PKB_1 514 522 PF00069 0.387
MOD_Plk_1 139 145 PF00069 0.346
MOD_Plk_1 156 162 PF00069 0.324
MOD_Plk_1 322 328 PF00069 0.589
MOD_Plk_1 438 444 PF00069 0.540
MOD_Plk_4 17 23 PF00069 0.441
MOD_Plk_4 214 220 PF00069 0.414
MOD_Plk_4 260 266 PF00069 0.515
MOD_Plk_4 338 344 PF00069 0.400
MOD_Plk_4 438 444 PF00069 0.543
MOD_Plk_4 504 510 PF00069 0.569
MOD_Plk_4 97 103 PF00069 0.375
MOD_ProDKin_1 148 154 PF00069 0.355
MOD_ProDKin_1 181 187 PF00069 0.502
MOD_ProDKin_1 315 321 PF00069 0.534
MOD_ProDKin_1 491 497 PF00069 0.500
TRG_DiLeu_BaLyEn_6 342 347 PF01217 0.550
TRG_ENDOCYTIC_2 115 118 PF00928 0.408
TRG_ER_diArg_1 306 308 PF00400 0.557
TRG_ER_diArg_1 357 359 PF00400 0.425
TRG_ER_diArg_1 394 396 PF00400 0.590
TRG_ER_diArg_1 503 505 PF00400 0.556
TRG_Pf-PMV_PEXEL_1 162 167 PF00026 0.447

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1IJM7 Leptomonas seymouri 67% 94%
A0A0S4IR28 Bodo saltans 39% 99%
A0A1X0P5F7 Trypanosomatidae 53% 97%
A0A3Q8IGH2 Leishmania donovani 99% 100%
A0A422NRA5 Trypanosoma rangeli 50% 99%
A4HN14 Leishmania braziliensis 83% 100%
C9ZYZ4 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 50% 97%
E9AFH1 Leishmania major 95% 100%
E9B6M6 Leishmania mexicana (strain MHOM/GT/2001/U1103) 94% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS